Renal Function Assessment in Critically Ill Children

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 20, 2018

Primary Completion Date

February 7, 2021

Study Completion Date

February 7, 2021

Conditions
IohexolPharmacokineticsRenal FunctionCritically Ill ChildrenAcute Kidney InjuryAugmented Renal Clearance
Interventions
DIAGNOSTIC_TEST

iohexol administration

IV injection of weight-dependent low dose of iohexol at time 0

DIAGNOSTIC_TEST

iohexol blood sampling

Blood sampling will be performed through an arterial (preferred) or venous line, other than the iohexol infusion line. In the first 30 minutes after iohexol injection, a blood sample of 2 ml will be obtained for iohexol concentration measurement and determination of renal biomarkers serum creatinine, cystatin C, betatrace protein. Subsequently, 2 up to 5 additional blood samples of 0,5 ml will be obtained for iohexol determination at 60,120 ,180, 240 and 360 minutes after iohexol injection to calculate iohexol plasma clearance from the plasma disappearance curve

Trial Locations (1)

Unknown

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

University Ghent

OTHER

lead

University Hospital, Ghent

OTHER

NCT05179564 - Renal Function Assessment in Critically Ill Children | Biotech Hunter | Biotech Hunter